*Total award amount reflects Direct Costs only for the duration of the project
|
|
- Charla Sharp
- 5 years ago
- Views:
Transcription
1 Grants & Contracts Awards Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award: *Total award amount reflects Direct Costs only for the duration of the project January 2012 Principal Investigator: Ghassan K. Abou- Alfa, MD Department/Program: Medicine/Gastrointestinal Oncology Service Project Title: Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model Total Award* Amount: $59,071 Award Date: 01/11/12 Awarding Agency: Columbia University/National Cancer Institute Principal Investigator: Michael F. Berger, PhD Department/Program: Pathology/Genetics Research Project Title: Systematic Studies of Resistance to Targeted Anticancer Therapeutics Total Award* Amount: $359,126 Award Date: 01/17/12 Awarding Agency: Starr Cancer Consortium Principal Investigator: Samuel Danishefsky, PhD Project Title: T32 Grant from Weill Cornell Total Award* Amount: $47,993 Award Date: 01/13/12 Awarding Agency: Weill Medical College of Cornell University/National Institutes of Health Principal Investigator: Sara Olson, PhD Department/Program: Epidemiology & Biostatistics Project Title: International Case- Control Study of Malignant Glioma Total Award* Amount: $560,830 Award Date: 01/20/12 Awarding Agency: Baylor College of Medicine/National Cancer Institute 1 Memorial Sloan- Kettering Cancer Center
2 Principal Investigator: Eric Pamer, MD Department/Program: Medicine/Infectious Disease/Immunology Project Title: CC- Chemokines in Listeria Infection Total Award* Amount: $1,250,000 Award Date: 01/30/12 Awarding Agency: National Institute of Allergy and Infectious Diseases/National Institutes of Health Principal Investigator: John Petrini, PhD Department/Program: Molecular Biology Project Title: Regulation of the DNA Damage Response by the Mre11 Complex Total Award* Amount: $1,251,829 Award Date: 01/30/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Craig B. Thompson, MD Project Title: Lymphocyte Survival: Implications for Lymphomagenesis Total Award* Amount: $70,594 Award Date: 01/13/12 Project Duration: 6 Months Principal Investigator: Paul Vadola, PhD Project Title: Synthesis of a Homogenous Erythropoietin via Iterative Native Chemical and Alanine Ligations Total Award* Amount: $99,724 Award Date: 01/13/12 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health February 2012 Principal Investigator: Mary Alpaugh, PhD Project Title: The Role of Bone Marrow- Derived Progenitor Cells and Tumor Emboli- Derived Exosomes in Malignant Progression of IBC Total Award* Amount: $10,000 Award Date: 02/06/12 2 Memorial Sloan- Kettering Cancer Center
3 Awarding Agency: The Mary Kay Foundation/Weill Medical College of Cornell University Principal Investigator: Hisham Bazzi, PhD Department/Program: Developmental Biology Project Title: Centrosomes and Hedgehog Signaling in Development and Polycystic Kidney Disease Total Award* Amount: $113,404 Award Date: 02/02/12 Awarding Agency: National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health Principal Investigator: Richard D. Carvajal, MD Department/Program: Medicine/Melanoma & Sarcoma Service Project Title: Per Case Reimbursement for Operational Costs at the Site Related for the NCI- CTEP Trial #8443 Total Award* Amount: $100,000 Award Date: 02/15/12 Project Duration: 3 Months Awarding Agency: Westat, Inc./National Cancer Institute Principal Investigator: Gabriela Chiosis, PhD Department/Program: Medicine/Breast Cancer Medicine/Molecular Pharmacology & Chemistry Project Title: Biomarkers of Response to Hsp90 Inhibitors in Triple- Negative Breast Cancer Total Award* Amount: $239,250 Award Date: 02/29/12 /National Institutes of Health Principal Investigator: Sarat Chandarlapaty, MD Department/Program: Medicine/Breast Cancer Medicine Service Project Title: Therapeutic Targeting of the Pl3K Enzymes in Breast Cancer Total Award* Amount: $10,000 Award Date: 02/07/12 Awarding Agency: Clinical and Translational Science Center/ National Center for Research Resources Principal Investigator: Samuel Danishefsky, PhD Project Title: R01 Aim 3 Danishefsky Total Award* Amount: $100,000 3 Memorial Sloan- Kettering Cancer Center
4 Award Date: 02/27/12 Project Duration: 6 Months Awarding Agency: Duke University Medical Center/ National Institutes of Health Principal Investigator: Mithat Gonen, PhD Department/Program: Epidemiology & Biostatistics Project Title: Maximum Entropy Estimation of Molecular and Genetic Diversity Total Award* Amount: $25,989 Award Date: 02/27/12 Awarding Agency: Dana Farber Cancer Institute/National Cancer Institute Principal Investigator: James J. Hsieh, MD, PhD Department/Program: Medicine/Genitourinary Oncology Service Project Title: Integrated Analyses of Taspase 1 (MLL Cleaving Protease) Total Award* Amount: $60,916 Award Date: 02/14/12 Project Duration: 13.5 Months /National Institutes of Health Principal Investigator: Yelena Y. Janjigian, MD Department/Program: Medicine/Gastrointestinal Oncology Service Project Title: Phase 2 Irinotecan for Treatment of p53 wr Gastric Adenocarcinoma Total Award* Amount: $18,491 Award Date: 02/22/12 Awarding Agency: Weill Medical College of Cornell University/ Food and Drug Administration Principal Investigator: William R. Jarnagin, MD, FACS Department/Program: Surgery/Hepatopancreatobiliary Service Project Title: Clinical Translation of Deformation Compensation for Image- Guided Liver Total Award* Amount: $106,193 Award Date: 02/03/12 Awarding Agency: Vanderbilt University/National Institutes of Health Principal Investigator: Ingo K. Mellinghoff, MD Department/Program: Neurology/Neurology Service Project Title: Ivy Foundation Early Phase Clinical Trials Consortium Total Award* Amount: $312,231 Award Date: 02/15/12 4 Memorial Sloan- Kettering Cancer Center
5 Awarding Agency: University of California, San Francisco/Ben and Catherine Ivy Foundation, The Principal Investigator: Gavril W. Pasternak, MD, PhD Department/Program: Neurology/Neurology Service/Molecular Pharmacology & Chemistry Project Title: Biochemical Characterization of Opioid Binding Sites Total Award* Amount: $604,258 Award Date: 02/07/12 Awarding Agency: National Institute on Drug Abuse/National Institutes of Health Principal Investigator: Stewart Shuman, MD, PhD Department/Program: Medicine/Departmental/Molecular Biology Project Title: mrna Capping Enzymes Total Award* Amount: $1,511,488 Award Date: 02/09/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Daniel Thorek, PhD Project Title: Multimodal, High Resolution and Dynamic Imaging of Sentinel and Distal Metastatic Lymph Nodes Using Intra- Lymphatic 18F- FDG Mapping Total Award* Amount: $60,000 Award Date: 02/08/12 Awarding Agency: Society of Nuclear Medicine Principal Investigator: Ann Zauber, PhD Department/Program: Epidemiology & Biostatistics Project Title: Optimizing Colonoscopy & Fecal Immunochemical Tests for Community- Based Screening Total Award* Amount: $30,638 Award Date: 02/28/12 Awarding Agency: Kaiser Foundation Research Institute/National Institutes of Health March 2012 Principal Investigator: Kathryn Anderson, PhD Department/Program: Developmental Biology Project Title: Tissue- specific Roles of Axin in Canonical Wnt Signaling and Tumorigenesis Total Award* Amount: $239,250 5 Memorial Sloan- Kettering Cancer Center
6 Award Date: 03/23/12 Principal Investigator: Michelle S. Bradbury, MD, PhD Department/Program: Radiology/Neuroradiology Service Project Title: Renally Excreted Multimodal Core- Shell Silica Nanoparticles as Tumor- Selective Radiotherapeutic Platforms for Nanomedicine Total Award* Amount: $1,885,531 Award Date: 03/12/12 Principal Investigator: Maura N. Dickler, MD Department/Program: Medicine/Breast Cancer Medicine Service Project Title: An Assessment of Mdm2C Isoform Protein as a Prognostic Factor in Breast Cancer Total Award* Amount: $35,365 Award Date: 03/05/12 Awarding Agency: Hunter College/Clinical and Translational Science Center Principal Investigator: Jan Grimm, MD, PhD Department/Program: Radiology/Nuclear Medicine Service Project Title: Cerenkov- Emission Based Nanosensors to Detect Biologic Activities In Vivo Total Award* Amount: $900,000 Award Date: 03/08/12 Project Duration: 4 Years Awarding Agency: National Institute of Biomedical Imaging and Bioengineering/National Institutes of Health Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: Physical Science Oncology Center Training Program Total Award* Amount: $538,908 Award Date: 03/20/12 Principal Investigator: Hedvig Hricak, MD, PhD Department/Program: Radiology/Departmental/Molecular Pharmacology & Chemistry Project Title: Subcontract to Anonymize and Transfer Radiological Imaging Data for The Cancer Imaging 6 Memorial Sloan- Kettering Cancer Center
7 Archive Total Award* Amount: $6,000 Award Date: 03/23/12 Awarding Agency: SAIC- Frederick/National Cancer Institute Research and Technology Management Principal Investigator: Clifford Hudis, MD Department/Program: Medicine/Breast Cancer Medicine Service Project Title: TBCRC 20: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed with Lobular Neoplasia of the Breast by Core Needle Biopsy Total Award* Amount: $4,200 Award Date: 03/13/12 Awarding Agency: Johns Hopkins University/Breast Cancer Research Foundation Principal Investigator: Katharine C. Hsu, MD, PhD Department/Program: Bone Marrow Transplant Service Project Title: Hematopoeitic Stem Cell Transplantation Total Award* Amount: $23,966 Award Date: 03/20/12 Awarding Agency: Fred Hutchinson Cancer Research Center/National Institute of Allergy and Infectious Diseases Principal Investigator: Neil Lipman, VMD Department/Program: Metastasis Research Center Project Title: Tri- Institutional Training Program in Laboratory Animal Medicine and Science Total Award* Amount: $473,764 Award Date: 03/30/12 Project Duration: 4 Years Awarding Agency: National Institutes of Health - Office of the Director Principal Investigator: Scott Keeney, PhD Department/Program: Molecular Biology Project Title: Mechanism of Meiotic Recombination Initiation in Yeast Total Award* Amount: $887,896 Award Date: 03/26/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences 7 Memorial Sloan- Kettering Cancer Center
8 Principal Investigator: Richard N. Kolesnick, MD Department/Program: Medicine/Endocrinology/Molecular Pharmacology & Chemistry Project Title: Re- setting the Endothelial Ceramide Rheostat Total Award* Amount: $1,037,500 Award Date: 03/30/12 Awarding Agency: National Heart, Lung, and Blood Institute Principal Investigator: Douglas A. Levine, MD Department/Program: Surgery/Gynecology Service Project Title: Prevention of Ovarian High- Grade Serous Carcinoma by Elucidating its Early Changes Total Award* Amount: $244,139 Award Date: 03/07/12 Awarding Agency: Johns Hopkins University/National Institutes of Health Principal Investigator: Ross Levine, MD Department/Program: Medicine/Human Oncology & Pathogenesis Program (HOPP) Project Title: Molecular Pathogenesis and Therapy of Myeloproliferative Neoplasms Total Award* Amount: $523,810 Award Date: 03/22/12 Awarding Agency: Leukemia and Lymphoma Society Principal Investigator: Elisa Oricchio, PhD Project Title: Indentifying New Therapeutic Targets in Follicular Lymphoma. Total Award* Amount: $185,715 Award Date: 03/22/12 Awarding Agency: Leukemia and Lymphoma Society Principal Investigator: Andrea Pusic, MD, MHS Department/Program: Surgery/Plastic and Reconstructive Surgical Service Project Title: Mastectomy Reconstruction Outcomes Consortium (MROC) Study Total Award* Amount: $418,320 Award Date: 03/06/12 Awarding Agency: University of Michigan Cancer Center/National Institutes of Health Principal Investigator: Jessica Rios, BS Department/Program: Cell Biology 8 Memorial Sloan- Kettering Cancer Center
9 Project Title: Biochemical and Functional Analysis of Wnt Acyltransferase, Porcupine Total Award* Amount: $126,696 Award Date: 03/29/12 Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Alberto Rosello- Diez, PhD Department/Program: Developmental Biology Project Title: Examining Growth Coordination Between Left and Right Sides of the Developing Vertebrate Body Total Award* Amount: $164,980 Award Date: 03/30/12 Awarding Agency: Human Frontier Science Program Principal Investigator: Stewart Shuman, MD, PhD Department/Program: Medicine/Departmental/Molecular Biology Project Title: Viral and Microbial RNA Modifying Enzymes Total Award* Amount: $1,473,415 Award Date: 03/23/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences April 2012 Principal Investigator: Arjun Balar, MD Department/Program: Medicine Project Title: Phase II Study of Gemcitabine and Pazopanib in Cisplatin Ineligible Patients with Metastatic Urothelial Cancer and the Potential Impact of Inherited Genetic Variation on Outcomes Total Award* Amount: $47,500 Award Date: 04/02/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Omar Abdel- Wahab, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Understanding and Targeting Epigenetic Alterations in Acquired Bone Marrow Failure Total Award* Amount: $300,000 Award Date: 04/20/12 Awarding Agency: DOD - Department of Defense 9 Memorial Sloan- Kettering Cancer Center
10 Principal Investigator: Richard D. Carvajal, MD Department/Program: Medicine/Melanoma & Sarcoma Service Project Title: Human Melanoma: Etiology, Progression and Therapy Total Award* Amount: $43,798 Award Date: 04/13/12 Awarding Agency: University of California, San Francisco/National Cancer Institute Principal Investigator: Stephen Chung, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Characterization of CD99 as a Therapeutic Target in MDS and AML Total Award* Amount: $47,500 Award Date: 04/02/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Alexander Drilon, MD Department/Program: Medicine Project Title: A Phase II Trial of Subcutaneous Bortezomib and Analysis of the NF- kb Pathway in a Molecularly- Selected Cohort of Advanced Previously- Treated KRAS G12D- Mutant Lung Adenocarcinoma Total Award* Amount: $47,500 Award Date: 04/02/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: James Harding, MD Department/Program: Medicine Project Title: An Evaluation of the Therapeutic and Molecular Effects of Histone Deacetylase Inhibition in Metastatic Uveal Melanoma Total Award* Amount: $47,500 Award Date: 04/02/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Elizabeth H. Lacy, PhD Department/Program: Developmental Biology Project Title: Genetic Pathways Directing Ventral Folding Morphogenesis in Mammalian Embryos Total Award* Amount: $1,307,760 Award Date: 04/13/12 Awarding Agency: National Institute of Child Health and Human Development 10 Memorial Sloan- Kettering Cancer Center
11 Principal Investigator: Julian Lange, PhD Department/Program: Molecular Biology Project Title: Regulating the Number and Distribution of DNA Breaks in Mammalian Meiosis Total Award* Amount: $52,000 Award Date: 04/02/12 Awarding Agency: American Cancer Society Principal Investigator: Christina Leslie, PhD Department/Program: Computational Biology Project Title: Integrative Analysis Tools to Dissect Cell- Type Specific Transcriptional Programs in Mammalian Cells Total Award* Amount: $1,142,215 Award Date: 04/23/12 Awarding Agency: National Human Genome Research Institute Principal Investigator: Hans G. Lilja, MD, PhD Department/Program: Clinical Chemistry Project Title: SPORE in Prostate Cancer Total Award* Amount: $20,000 Award Date: 04/03/12 Awarding Agency: Mayo Clinic Rochester/National Cancer Institute Principal Investigator: Sadek Nehmeh, PhD Department/Program: Medical Physics Project Title: Prognostic Value of Tumor Hypoxia, as Measured by 18F- FMISO Breath Hold PET/CT Total Award* Amount: $960,753 Award Date: 04/27/12 Principal Investigator: Jamie Ostroff, PhD Department/Program: Psychiatry Project Title: Implementing Tobacco Use Treatment Guidelines in Dental Public Health Clinics Total Award* Amount: $145,445 Award Date: 04/30/12 Awarding Agency: New York University School of Medicine/National Cancer Institute 11 Memorial Sloan- Kettering Cancer Center
12 Principal Investigator: Paul Paik, MD Department/Program: Medicine Project Title: Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ- MAP) Total Award* Amount: $187,399 Award Date: 04/05/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Charles Sawyers, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Understanding Resistance to Next Generation Antiandrogens Total Award* Amount: $1,176,525 Award Date: 04/27/12 Principal Investigator: Charles A. Sklar, MD Department/Program: Long- Term Follow- Up Project Title: Childhood Cancer Survivor Study Total Award* Amount: Award Date: $325,500 Awarding Agency: Saint Jude Children's Research Hospital/National Cancer Institute Principal Investigator: Derek Tan, PhD Project Title: Small Molecule Inhibitors of P. aeruginosa Quinolone (Pqs) Quorum Sensing Total Award* Amount: $266,632 Award Date: 04/02/12 Awarding Agency: National Institute of Allergy and Infectious Diseases Principal Investigator: Martin Voss, MD Department/Program: Genitourinary Oncology Project Title: Predictive Tissue Biomarkers for mtor Inhibitors in Advanced Renal Cell Carcinoma (RCC) Total Award* Amount: $47,500 Award Date: 04/02/12 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology 12 Memorial Sloan- Kettering Cancer Center
13 Principal Investigator: Rona Yaeger, MD Project Title: Targeting PI3K/AKT effector signaling in KRAS mutant colorectal tumors Total Award* Amount: $98,000 Award Date: 04/02/12 Awarding Agency: American Cancer Society May 2012 Principal Investigator: Peter J. Allen, MD, FACS Department/Program: Surgery/Hepatopancreatobiliary Service Project Title: Pancreatic Cystic Reference Set Total Award* Amount: $20,023 Award Date: 05/02/12 Awarding Agency: University of Pittsburgh School of Medicine/ National Cancer Institute Principal Investigator: Kathryn Anderson, PhD Department/Program: Developmental Biology Project Title: Genetic Analysis of Mouse Nervous System Development Total Award* Amount: $1,597,975 Award Date: 05/08/12 Awarding Agency: National Institute of Neurological Disorders and Stroke Principal Investigator: Peter Bach, MD, MAPP Department/Program: Epidemiology & Biostatistics Project Title: Radiomics of Lung Cancer Screening Total Award* Amount: $73,089 Award Date: 05/30/12 Awarding Agency: H. Lee Moffitt Cancer Center & Research Institute Principal Investigator: Rashmi Bhardwaj, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: The Role of Ribosomal Protein Deficiency in Pathogenesis of Bone Marrow Total Award* Amount: $294,953 Award Date: 05/30/12 Awarding Agency: DOD - Department of Defense Principal Investigator: Ronald Blasberg, MD 13 Memorial Sloan- Kettering Cancer Center
14 Department/Program: Neurology/Neurology Service/Molecular Pharmacology & Chemistry Project Title: Tumor Microenvironment: Impact on T Cell Tumor-Targeting, Activation and Survival Total Award* Amount: $1,387,392 Award Date: 05/09/12 Principal Investigator: Gardner Creech, PhD Project Title: NCL with Induced a-helices: de Novo Chemical Synthesis of the ATAD2 Bromodomain Total Award* Amount: $148,518 Award Date: 05/16/12 Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Samuel Danishefsky, PhD Department/Program: Molecular Pharmacology & Chemistry Project Title: Synthesis of Antitumor Natural Products Total Award* Amount: $1,037,500 Award Date: 05/14/12 Principal Investigator: Joseph P. Erinjeri, MD, PhD Department/Program: Radiology/Interventional Radiology Service Project Title: Modulating Inflammation to Improve Treatment Response Following Thermal Ablation of Tumors Total Award* Amount: $152,000 Award Date: 05/21/12 Awarding Agency: Radiological Society of North America Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: RCAS-tva System Ependymoma Modeling Total Award* Amount: $200,000 Award Date: 05/02/12 Awarding Agency: CERN Foundation Principal Investigator: Ross Levine, MD 14 Memorial Sloan- Kettering Cancer Center
15 Department/Program: Medicine/Human Oncology & Pathogenesis Program (HOPP) Project Title: Investigation of the effects of Asxl1 loss on hematopoietic stem cell self- renewal Total Award* Amount: $5,000 Award Date: 05/03/12 Awarding Agency: American Society of Hematology Principal Investigator: Marcel Van Den Brink, MD, PhD Department/Program: Medicine/Division of Hematologic Oncology/Immunology Project Title: IL-22 in Thymic Regeneration Total Award* Amount: $1,374,175 Award Date: 05/31/12 Awarding Agency: National Institute of Allergy and Infectious Diseases Principal Investigator: Ryan Willett, PhD Department/Program: Developmental Biology Project Title: Roles of Engrailed Proteins in Granule Cells During Cerebellum Development Total Award* Amount: $148,518 Award Date: 05/25/12 Awarding Agency: National Institute of Neurological Disorders and Stroke August 2012 Principal Investigator: James Allison, PhD/Alexander Rudensky, PhD Department/Program: Medicine/Departmental/Immunology Project Title: Immunology Research Training Total Award* Amount: $1,107,912 Award Date: 08/01/12 Principal Investigator: Charlotte E. Ariyan, MD, PhD Department/Program: Surgery/Gastric and Mixed Tumor Service Project Title: Combining CTLA-4 Blockade with Regional Chemotherapy to Augment Antitumor Immunity in Melanoma Total Award* Amount: $100,000 Award Date: 08/21/12 Awarding Agency: Society of Surgical Oncology 15 Memorial Sloan- Kettering Cancer Center
16 Principal Investigator: Elena Elkin, PhD Department/Program: Biostatistics Project Title: Medical Decision Making in Cancer Total Award* Amount: $10,000 Award Date: 08/20/12 Research and Technology Management Principal Investigator: Jenna Goldberg, MD Department/Program: Bone Marrow Transplant Service Project Title: Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)- Project 1 Total Award* Amount: $13,598 Award Date: 08/23/12 Awarding Agency: Fred Hutchinson Cancer Research Center/National Cancer Institute Principal Investigator: Jenna Goldberg, MD Department/Program: Bone Marrow Transplant Service Project Title: Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT)- Project 2 Total Award* Amount: $16,802 Award Date: 08/23/12 Awarding Agency: Fred Hutchinson Cancer Research Center/National Cancer Institute Principal Investigator: Alan M. Hanash, MD, PhD Department/Program: Medicine Project Title: IL-22 in Epithelial Regeneration After Allogeneic Transplant Total Award* Amount: $633,125 Award Date: 08/24/12 Awarding Agency: National Heart, Lung, and Blood Institute Principal Investigator: Kitai Kim, PhD Project Title: Hematopoietic Potential of Histocompatible Embryonic Stem Cell Lines Total Award* Amount: $488,710 Award Date: 08/21/12 Project Duration: 7 Years Awarding Agency: National Heart, Lung, and Blood Institute Principal Investigator: Moritz F. Kircher, MD, PhD Department/Program: Radiology Project Title: Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual- 16 Memorial Sloan- Kettering Cancer Center
17 Modality MRI-Raman Nanoparticle Total Award* Amount: $827,500 Award Date: 08/06/12 Principal Investigator: Robert Klein, PhD Project Title: Identification of Regulatory Cancer Risk SNPs for Chemoprevention Discovery Total Award* Amount: $100,000 Award Date: 08/02/12 Principal Investigator: Ross Levine, MD Department/Program: Medicine/Human Oncology & Pathogenesis Program (HOPP) Project Title: Targeting Cytosine Hydroxymethylation in AML Stem Cells Total Award* Amount: $540,054 Award Date: 08/24/12 Awarding Agency: Leukemia and Lymphoma Society Principal Investigator: Yueming Li, PhD Project Title: Regulation and Function of Gamma-Secretase Total Award* Amount: $459,500 Award Date: 08/21/12 Awarding Agency: National Institute on Aging Principal Investigator: Hans G. Lilja, MD, PhD Department/Program: Clinical Chemistry Project Title: Prospective Validation of a Multi-Marker Prostate Cancer Prediction Model Total Award* Amount: $1,483,802 Award Date: 08/08/12 Project Duration: 4 Years Principal Investigator: Scott Lowe, PhD Project Title: Computational and Functional Approaches to Validating Cancer Genome Targets. Proj 5 Total Award* Amount: $1,072,120 Award Date: 08/30/12 17 Memorial Sloan- Kettering Cancer Center
18 Awarding Agency: Cold Spring Harbor Laboratory/National Institutes of Health Principal Investigator: Srinivas Malladi, PhD Project Title: Candidate Mediators of Latent Metastasis: Identification and Validation Total Award* Amount: $150,000 Award Date: 08/13/12 Awarding Agency: American Cancer Society Principal Investigator: Joan Massagué, PhD Project Title: Dissecting and Targeting Latent Metastasis Total Award* Amount: $5,000,000 Award Date: 08/20/12 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Christian J. Nelson, PhD Department/Program: Psychiatry and Behavioral Sciences Project Title: Decision Making For Active Surveillance in Prostate Cancer Patients and Spouses Total Award* Amount: $311,222 Award Date: 08/20/12 Principal Investigator: Sun Park, PhD Project Title: Characterization of the Role of Msi2 in Hematopoiesis Total Award* Amount: $140,000 Award Date: 08/22/12 Awarding Agency: Tri-Institutional Stem Cell Initiative Principal Investigator: Dinshaw J. Patel, PhD Department/Program: Structural Biology Project Title: Functions and Mechanisms of E-Box Binding Transcription Factors in AML1- ETO Mediated Leukemogenesis Total Award* Amount: $600,000 Award Date: 08/29/12 Awarding Agency: Starr Cancer Consortium 18 Memorial Sloan- Kettering Cancer Center
19 Principal Investigator: Fabiana Perna, PhD Project Title: Investigations into a Novel Epigenetic Silencing Mechanism of Globin Gene Expression Total Award* Amount: $100,000 Award Date: 08/17/12 Awarding Agency: American Society of Hematology Principal Investigator: Michel Sadelain, MD, PhD Department/Program: Medicine/Hematology/Molecular Pharmacology & Chemistry Project Title: Genetic Approaches to Cancer Immunotherapy Total Award* Amount: $8,641,801 Award Date: 08/30/12 Project Duration: 7 Years Principal Investigator: Gary Schwartz, MD Department/Program: Medicine/Melanoma and Sarcoma Project Title: Co-Chair of the Experimental Therapeutics Committee Total Award* Amount: $6,818 Award Date: 08/16/12 Awarding Agency: Alliance for Clinical Trials in Oncology Foundation Principal Investigator: Lorenz Studer, MD Department/Program: Neurosurgery/Departmental/Developmental Biology Project Title: PD ips Cell Line Consortium Total Award* Amount: $199,714 Award Date: 08/15/12 Awarding Agency: McLean Hospital/National Institute of Neurological Disorders and Stroke Principal Investigator: Brian Zeglis, BS Department/Program: Radiology Project Title: PET Imaging of Oxidative Stress in Prostate Cancer Total Award* Amount: $75,000 Award Date: 08/28/12 Awarding Agency: Congressionally Directed Medical Research Programs September 2012 Principal Investigator: Goutam Chakraborty, PhD Department/Program: Cell Biology 19 Memorial Sloan- Kettering Cancer Center
20 Project Title: Inhibition of Prostate Tumor Progression by Neogenin Total Award* Amount: $115,000 Award Date: 09/30/12 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Timothy Chan, MD, PhD Department/Program: Radiation Oncology Project Title: The Mutational Landscapes Underlying Aggressiveness in Adenoid Cystic Carcinoma Total Award* Amount: $275,000 Award Date: 09/24/12 Awarding Agency: National Institute of Dental and Craniofacial Research Principal Investigator: Ping Chi, MD Department/Program: Medicine Project Title: An Integrative Approach to Target Lineage-Specific Oncogenic Transcription Factors Total Award* Amount: $1,500,000 Award Date: 09/13/12 Principal Investigator: Lisa Diamond, MD Department/Program: Psychiatry & Behavioral Sciences Project Title: Impact of Physician non-english Language Proficiency Level on Cancer Screening Total Award* Amount: $254,650 Award Date: 09/27/12 Principal Investigator: Mark Dunphy, DO Department/Program: Nuclear Medicine Project Title: First Human Trial of Src/Abl-Targeted Cancer Imaging with F-18 SKI PET Total Award* Amount: $415,000 Award Date: 09/18/12 Principal Investigator: Francesca Gany, MD Department/Program: Psychiatry & Behavioral Sciences Project Title: South Asian Health: From Research to Practice and Policy 20 Memorial Sloan- Kettering Cancer Center
21 Total Award* Amount: $49,941 Award Date: 09/26/12 Awarding Agency: National Institute of Child Health and Human Development Principal Investigator: Jan Grimm, MD, PhD Department/Program: Radiology/Nuclear Medicine Project Title: Prognosticating Nanoparticles for Molecular Imaging of Prostate Cancer Total Award* Amount: $225,000 Award Date: 09/11/12 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Daniel Heller, PhD Project Title: Transient Metabolite Detection for Single-Cell Metabolomics and Diagnostics Total Award* Amount: $1,500,000 Award Date: 09/21/12 Awarding Agency: National Institute of Child Health and Human Development Principal Investigator: Clifford Hudis, MD Department/Program: Medicine/Breast Cancer Medicine Project Title: Role of Mechanical Properties of Obesity-Asociated Stroma in Breast Cancer Total Award* Amount: $11,250 Award Date: 09/11/12 Awarding Agency: Clinical and Translational Science Center/National Center for Advancing Translational Sciences Principal Investigator: Robert Klein, PhD Project Title: Linking Disease-Associated Variants to Transcriptional Regulation Using ENCODE Total Award* Amount: $1,079,717 Award Date: 09/19/12 Awarding Agency: National Human Genome Research Institute Principal Investigator: Mark Kris, MD Department/Program: Medicine/Thoracic Oncology Project Title: Targets for Therapy for Carcinomas of the Lung Total Award* Amount: $10,721,659 Award Date: 09/12/12 21 Memorial Sloan- Kettering Cancer Center
22 Principal Investigator: Ross Levine, MD Department/Program: Medicine/Human Oncology & Pathogenesis Program (HOPP) Project Title: Enhancing Targeted Therapy for Myeloproliferative Neoplasms Total Award* Amount: $53,704 Award Date: 09/27/12 Awarding Agency: H. Lee Moffitt Cancer Center & Research Institute/Congressionally Directed Medical Research Programs Principal Investigator: Susruta Majumdar, PhD Department/Program: Neurology Project Title: Analgesics Targeting Truncated Transmembrane Exon 11 Variants of MOR-1 (6TM-E11) Total Award* Amount: $246,926 Award Date: 09/10/12 Awarding Agency: National Institute on Drug Abuse Principal Investigator: Christine Mayr, MD Project Title: Dissecting the Role of Alternative 3'UTRs in Cancer with 3'-seq Total Award* Amount: $1,300,588 Award Date: 09/07/12 Project Duration: 4 Years Principal Investigator: Christian J. Nelson, PhD Department/Program: Psychiatry and Behavioral Sciences Project Title: Identifying and Measuring Depression in Older Cancer Patients Total Award* Amount: $290,560 Award Date: 09/24/12 Principal Investigator: Philipp Niethammer, PhD Department/Program: Cell Biology Project Title: Regulation of Wound Detection in Animal Tissues Total Award* Amount: $950,000 Award Date: 09/13/12 Awarding Agency: National Institute of General Medical Sciences 22 Memorial Sloan- Kettering Cancer Center
23 Principal Investigator: Alexandros Pertsinidis, PhD Department/Program: Structural Biology Project Title: Understanding Gene Transcription from First-Principles: A Single-Molecule Study Total Award* Amount: $1,500,000 Award Date: 09/21/12 Awarding Agency: National Institute of General Medical Sciences/National Institutes of Health Principal Investigator: Chris Sander, PhD Department/Program: Epidemiology & Biostatistics/Biostatistics/Computational Biology Project Title: Pathway Commons: A Public Library of Biological Pathways Total Award* Amount: $2,031,725 Award Date: 09/21/12 Awarding Agency: National Human Genome Research Institute/NIH Principal Investigator: Derek Tan, PhD Project Title: Rational Design of Adenylation Enzyme Inhibitors Total Award* Amount: $316,182 Award Date: 09/13/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Craig B. Thompson, MD Project Title: Cancer Center Support Grant Total Award* Amount: $27,191 Award Date: 09/14/12 Principal Investigator: Craig B. Thompson, MD Project Title: Cancer Center Support Grant Total Award* Amount: $41,006 Award Date: 09/14/12 Principal Investigator: Craig B. Thompson, MD Project Title: Cancer Center Support Grant 23 Memorial Sloan- Kettering Cancer Center
24 Total Award* Amount: $136,687 Award Date: 09/19/12 Principal Investigator: Ann Zauber, PhD Department/Program: Epidemiology & Biostatistics Project Title: Modeling Effective Health Policies for Colorectal Cancer Total Award* Amount: $2,973,095 Award Date: 09/20/12 August 2012 Principal Investigator: Samuel Danishefsky, PhD Project Title: Synthesis Directed Toward Therapeutic Agents Total Award* Amount: $1,280,003 Award Date: 08/30/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Jenna Goldberg, MD Department/Program: Bone Marrow Transplant Service Project Title: Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplants (HCT) - Pilot 1 Total Award* Amount: $9,200 Award Date: 08/01/12 Awarding Agency: Fred Hutchinson Cancer Research Center/National Cancer Institute Principal Investigator: Eric Lai, PhD Department/Program: Developmental Biology Project Title: Non-Canonical mirna Biogenesis Mechanisms in Drosophila and Mammals Total Award* Amount: $1,053,281 Award Date: 08/30/12 Project Duration: 4 Years Awarding Agency: National Institute of General Medical Sciences Principal Investigator: Alexander Rudensky, PhD Department/Program: Immunology Project Title: Immunology Research Training Total Award* Amount: $1,107,912 Award Date: 08/01/12 24 Memorial Sloan- Kettering Cancer Center
25 INTERNAL COMPETITIONS Principal Investigator: Leila Akkari, PhD Project Title: Unraveling the Role of Cysteine Cathepsin Proteases in the Brain Tumor Microenvironment Total Award* Amount: $80,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center 25 Memorial Sloan- Kettering Cancer Center
26 Principal Investigator: Robert Benezra, PhD Project Title: Neutrophil Mediated Anti-Metastatic Therapy Total Award* Amount: $352,000 Award Date: 08/10/12 Awarding Agency: Metastasis Research Center Research and Technology Management Principal Investigator: Christian Grommes, MD Department/Program: Neurology Project Title: Exploring the Role of the PI3(K) Pathway in Tumor Maintenance and Therapy Response in Primary CNS Lymphoma Total Award* Amount: $80,000 Award Date: 08/01/12 Awarding Agency: Brain Tumor Center Principal Investigator: Daniel Heller, PhD Project Title: Real-Time In Vivo Marker Detection for Rapid Measurement of Metastasis Onset Total Award* Amount: $400,000 Award Date: 08/10/12 Awarding Agency: Metastasis Research Center Principal Investigator: Johanna A. Joyce, PhD Project Title: Developing Novel Strategies to Target Tumor Cell-Macrophage Interactions in Brain Metastasis Total Award* Amount: $400,000 Award Date: 08/10/12 Awarding Agency: Metastasis Research Center Principal Investigator: Gary Mason, MD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Elucidating the Oncogenic Effects of Histone Protein Mutations in Pediatric Glioma Total Award* Amount: $80,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center 26 Memorial Sloan- Kettering Cancer Center
27 Principal Investigator: Thomas Reiner, PhD Department/Program: Radiology Project Title: Novel Bioorthogonal Strategies for Glioblastoma-Targeted Peptidic PET Probes Total Award* Amount: $80,000 Award Date: 08/09/12 Awarding Agency: Brain Tumor Center Principal Investigator: Sriram Venneti, MD, PhD Project Title: Evaluation of Glutamine Metabolism in Gliomas Using Biochemical and In Vivo PET Imaging Approaches Total Award* Amount: $80,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Hans-Guido Wendel, MD Project Title: New Therapeutic Opportunities in Follicular Lymphoma Total Award* Amount: $400,000 Award Date: 08/01/12 Awarding Agency: Geoffrey Beene Cancer Research Center Principal Investigator: Alexandre Wojcinski, PhD Department/Program: Developmental Biology Project Title: Identification of Genes and Cell Behaviors Regulated by HH/GLI2 Signaling During Medulloblastomas Tumor Progression Total Award* Amount: $80,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Nancy Lee, MD Department/Program: Radiation Oncology Project Title: Hypoxia Image-Guided Radiation Therapy Total Award* Amount: $1,196,105 Award Date: 07/31/12 Principal Investigator: Timothy Chan, MD, PhD Department/Program: Radiation Oncology Project Title: P01 Interim Application 27 Memorial Sloan- Kettering Cancer Center
28 Total Award* Amount: $100,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: P01 Interim Application Total Award* Amount: $100,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Jason T. Huse, MD, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: P01 Interim Application Total Award* Amount: $64,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Johanna A. Joyce, PhD Project Title: P01 Interim Application Total Award* Amount: $100,000 Award Date: 08/15/12 Awarding Agency: Brain Tumor Center Principal Investigator: Tim A. Ahles, PhD Department/Program: Psychiatry/Neuropsychiatry Project Title: The CCNY/MSKCC Partnership for Research Training and Outreach Total Award* Amount: $4,546,069 Award Date: 09/20/12 Principal Investigator: Tim A. Ahles, PhD Department/Program: Psychiatry/Neuropsychiatry Project Title: The CCNY/MSKCC Partnership for Research Training and Outreach Total Award* Amount: $4,681,657 Award Date: 09/21/12 28 Memorial Sloan- Kettering Cancer Center
29 Principal Investigator: Zhirong Bao, PhD Department/Program: Developmental Biology Project Title: An Integrated System to Monitor Complex Tissues at Single-Cell Resolution Total Award* Amount: $2,281,856 Award Date: 09/26/12 Awarding Agency: National Institute of Child Health and Human Development Principal Investigator: Jonine Bernstein, PhD Department/Program: Epidemiology & Biostatistics Project Title: Mammographic Density and Risk of Contralateral Breast Cancer Total Award* Amount: $1,492,868 Award Date: 09/19/12 Principal Investigator: Luca Cartegni, PhD Project Title: Controlled Premature Termination of Translation to Generate Designated Truncated Variants Total Award* Amount: $413,250 Award Date: 09/20/12 Principal Investigator: Katharine C. Hsu, MD, PhD Department/Program: Bone Marrow Transplant Service Project Title: Phase 1 Study of Immunotherapy with NK Cells anti-gd2 for Neuroblastoma Total Award* Amount: $331,303 Award Date: 09/11/12 Awarding Agency: Food and Drug Administration Principal Investigator: David P. Kelsen, MD Department/Program: Medicine/Gastrointestinal Oncology Service Project Title: The Cancer Genome Atlas Gastroesophageal Cancers Total Award* Amount: $46,124 Award Date: 09/07/12 Awarding Agency: SAIC-Frederick/ National Cancer Institute Principal Investigator: Wendy G. Lichtenthal, PhD Department/Program: Psychiatry & Behavioral Sciences Project Title: Attention and Interpretation Modification for Fear of Breast Cancer Recurrence (AIM-FBCR): An Intervention Development Study 29 Memorial Sloan- Kettering Cancer Center
30 Total Award* Amount: $90,000 Award Date: 09/12/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Ingo K. Mellinghoff, MD Department/Program: Neurology/Neurology Service Project Title: Molecular Mechanisms of IDH1-mediated Gliomagenesis Total Award* Amount: $1,194,094 Award Date: 09/20/12 Awarding Agency: National Institute of Neurological Disorders and Stroke October 2012 Principal Investigator: Dean F. Bajorin, MD Department/Program: Medicine/Genitourinary Oncology Service Project Title: K30 Research Education Total Award* Amount: $1,291,005 Award Date: 10/23/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Richard D. Carvajal, MD Department/Program: Medicine/Melanoma & Sarcoma Service Project Title: Participant and Clinical Interaction Resources Total Award* Amount: $904,235 Award Date: 10/23/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Nai-Kong Cheung, MD, PhD Department/Program: Pediatrics Project Title: Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients with High-Risk Neuoblastoma and GD2-Positive Tumors Total Award* Amount: $1,477,221 Award Date: 10/02/12 Awarding Agency: Congressionally Directed Medical Research Programs Principal Investigator: Katherine Fain, MPA Department/Program: Clinical Research 30 Memorial Sloan- Kettering Cancer Center
31 Project Title: Regulatory Knowledge and Support Total Award* Amount: $165,995 Award Date: 10/23/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Alberto Fernandez-Tejada, PhD Project Title: Vaccine Adjuvants Total Award* Amount: $24, Award Date: 10/14/12 Awarding Agency: European Union Principal Investigator: Alan L. Ho, MD, PhD Department/Program: Medicine/Head and Neck Oncology Project Title: Targeting the Oncogenic Transcription Factor c-myb in Adenoid Cystic Carcinomas Total Award* Amount: $622,500 Award Date: 10/03/12 Principal Investigator: Eric Holland, MD Department/Program: Neurosurgery/Departmental/Cancer Biology and Genetics Project Title: Non-neoplastic cell types dictate gliomagenesis and response to therapy Total Award* Amount: $324,055 Award Date: 10/15/12 Awarding Agency: Cleveland Clinic Foundation/National Cancer Institute Principal Investigator: Raya Khanin, PhD Department/Program: Research Facilities Project Title: Bioinformatics Total Award* Amount: $1,232,775 Award Date: 10/23/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Michael LaQuaglia, MD Department/Program: Pediatric Surgical Service Project Title: Children's Oncology Group: Scientific Leadership Chair Grant Total Award* Amount: $11, Memorial Sloan- Kettering Cancer Center
32 Award Date: 10/17/12 Awarding Agency: Children's Hospital of Philadelphia/National Cancer Institute Principal Investigator: Douglas A. Levine, MD Department/Program: Surgery/Gynecology Service Project Title: PROTOCOL GOG-0229N: Phase II Evaluation of ACE-041 Total Award* Amount: $118,009 Award Date: 10/17/12 Awarding Agency: Gynecological Oncology Group Principal Investigator: Douglas A. Levine, MD Department/Program: Surgery/Gynecology Service Project Title: The Cancer Genome Atlas: Retrospective Cases of Uterine Carcinosarcoma Total Award* Amount: $122,560 Award Date: 10/05/12 Awarding Agency: SAIC-Frederick/National Cancer Institute Principal Investigator: Babak J. Mehrara, MD Department/Program: Surgery/Plastic and Reconstructive Surgical Service Project Title: Mechanisms of Fibrosis and Lymphatic Dysfunction in Post-Surgical Lymphedema Total Award* Amount: $2,141,093 Award Date: 10/05/12 Awarding Agency: National Heart, Lung, and Blood Institute Principal Investigator: Dinshaw J. Patel, PhD Department/Program: Structural Biology Project Title: Chromatin Mechanisms and Epigenetic Targeting in Hematological Malignancies Total Award* Amount: $750,000 Award Date: 10/18/12 Awarding Agency: Northwestern University/Leukemia and Lymphoma Society Principal Investigator: George Plitas, MD Department/Program: Surgery Project Title: Impact of Regulatory T cells on the tumor microenvironment during breast carcinogenesis Total Award* Amount: $47,500 Award Date: 10/10/12 32 Memorial Sloan- Kettering Cancer Center
33 Awarding Agency: Conquer Cancer Foundation of the American Society of Clinical Oncology Principal Investigator: Milind Rajadhyaksha, PhD Department/Program: Medicine/Dermatology Project Title: Line-scanned MEMS-based dual-axes confocal microscopy to detect oral lesions in vivo Total Award* Amount: $785,190 Award Date: 10/18/12 Awarding Agency: Stony Brook University/National Institute of Dental and Craniofacial Research Principal Investigator: Jaya Satagopan, PhD Department/Program: Epidemiology & Biostatistics Project Title: Research Design and Biostatistics Total Award* Amount: $326,240 Award Date: 10/24/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Yiauchung Sheh, MS Project Title: Translational Technologies and Resources Total Award* Amount: $99,825 Award Date: 10/18/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Hans-Guido Wendel, MD Project Title: Improving Treatment of Follicular Lymphoma Total Award* Amount: $600,000 Award Date: 10/01/12 Awarding Agency: American Cancer Society Principal Investigator: Richard White, MD, PhD Project Title: BRAFV600E as a Regulator of Transcriptional Elongation Total Award* Amount: $50,000 Award Date: 10/23/12 33 Memorial Sloan- Kettering Cancer Center
34 Awarding Agency: American Association for Cancer Research Research and Technology Management Principal Investigator: Haiming Xu, PhD Department/Program: Human Oncology & Pathogenesis Program (HOPP) Project Title: Molecular Mechanism of Severe Cytopenia in a Mouse Model of Myelodysplastic Syndromes (MDS) Total Award* Amount: $299,954 Award Date: 10/17/12 Project Duration: Years Awarding Agency: Congressionally Directed Medical Research Programs November 2012 Principal Investigator: Katherine M. Bell-McGuinn, MD, PhD Department/Program: Medicine/Gynecologic Medical Oncology Project Title: Targeting the P13K Pathway in Women s Cancers Total Award* Amount: $58,035 Award Date: 11/02/12 Awarding Agency: Dana Farber Cancer Institute/Stand Up To Cancer Principal Investigator: Francesca Gany, MD Department/Program: Psychiatry & Behavioral Sciences Project Title: Assessing the Contribution of Transplantation Barriers to Disparities in Liver Cancer Survival in Minorities Total Award* Amount: $13,390 Award Date: 11/07/12 Awarding Agency: Mount Sinai School of Medicine/National Cancer Institute Principal Investigator: Francesca Gany, MD Department/Program: Psychiatry & Behavioral Sciences Project Title: The Taxi Network Total Award* Amount: $561,200 Award Date: 11/20/12 Awarding Agency: National Center on Minority Health and Health Disparities Principal Investigator: Richard N. Kolesnick, MD Department/Program: Medicine/Endocrinology/Molecular Pharmacology & Chemistry Project Title: Neutralization of Ceramide as a Novel Approach to Specifically Inhibit Acute GVHD Total Award* Amount: $93,976 Award Date: 11/12/12 34 Memorial Sloan- Kettering Cancer Center
35 Awarding Agency: Ceramide Therapeutics, LLC/National Institute of Allergy and Infectious Diseases Principal Investigator: Douglas A. Levine, MD Department/Program: Surgery/Gynecology Project Title: Proteome Characterization Center: A Genoproteomics Pipeline for Cancer (Verification Unit) Total Award* Amount: $15,252 Award Date: 11/03/12 Awarding Agency: Johns Hopkins University/National Cancer Institute Principal Investigator: Scott Lowe, PhD Project Title: Cold Spring Harbor Laboratory Cancer Research Center Total Award* Amount: $1,852,040 Award Date: 11/02/12 Project Duration: 4 Years Awarding Agency: Cold Spring Harbor Laboratory/National Cancer Institute Principal Investigator: Jamie Ostroff, PhD Department/Program: Psychiatry Project Title: Integrating Tobacco Treatment Into Cancer Care Total Award* Amount: $705,870 Award Date: 11/14/12 Awarding Agency: Massachusetts General Hospital/National Cancer Institute Principal Investigator: Si Jia Pan, PhD Project Title: Identification of Notch-1 and Notch-2 Modulators for Tumor Therapies Total Award* Amount: $45,941 Award Date: 11/07/12 Awarding Agency: Weill Medical College of Cornell University/National Cancer Institute Principal Investigator: Dinshaw J. Patel, PhD Department/Program: Structural Biology Project Title: Posttranscriptional Regulation by mrna-binding Shuttling and Transport Proteins Total Award* Amount: $832,500 Award Date: 11/14/12 Awarding Agency: Rockefeller University/National Institutes of Health 35 Memorial Sloan- Kettering Cancer Center
36 October 2012 Principal Investigator: Michelle S. Bradbury, MD, PhD Department/Program: Radiology/Neuroradiology Project Title: Renally Excreted Multimodal Silica Nanoparticles as Melanoma-Selective Therapies Total Award* Amount: $70,000 Award Date: 10/18/12 Awarding Agency: Clinical and Translational Science Center/National Center for Research Resources Principal Investigator: Samuel Danishefsky, PhD Project Title: Construction of Glycopeptide Immunogens Total Award* Amount: $106,902 Award Date: 10/19/12 Awarding Agency: Duke University Medical Center/National Institute of Allergy and Infectious Diseases Principal Investigator: Mark Frattini, MD, PhD Department/Program: Medicine/Leukemia Project Title: Genome-Wide Identification of DNA Methylation Biomarkers in AML Total Award* Amount: $19,112 Award Date: 10/16/12 Awarding Agency: Cornell University/National Institutes of Health Principal Investigator: Mark Kris, MD Department/Program: Medicine/Thoracic Oncology Project Title: Lung Cancer Mutation Consortium (LCMC) Total Award* Amount: $75,000 Award Date: 10/18/12 Awarding Agency: National Lung Cancer Partnership/University of Colorado at Denver Principal Investigator: Douglas A. Levine, MD Department/Program: Surgery/Gynecology Project Title: PROTOCOL GOG-0170R, A Phase II Evaluation of Dalantercept Total Award* Amount: $118,009 Award Date: 10/24/12 Awarding Agency: Gynecological Oncology Group 36 Memorial Sloan- Kettering Cancer Center
Research and Technology Management
Grants & Contracts Awards Processed by Grants & Contracts Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award (Based on information available
More informationFrontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA
N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More informationThe 2015 donations will be transformative:
2015 Impact Funding Allocations Cycle for Survival is determined to beat rare cancers by powering groundbreaking research. Participants and donors fight so all patients have the treatment options they
More informationGrants & Contracts Awards
Grants & Contracts Awards Processed by Grants & Contracts Join us as we congratulate the investigators listed below who have recently received a new or competitive renewal award: *Total award amount reflects
More informationResearch and Technology Management
Office of Technology Development - Sponsored Research Agreements Join us as we congratulate the Principal Investigators of new industry sponsored research agreements listed below: January 2012 Principal
More informationTHE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director
THE UC SANTA CRUZ GENOMICS INSTITUTE David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director April 8, 2015 OUR MISSION Unlocking the world s genomic data to accelerate medical
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationUCI. Anti-Cancer Challenge Impact report. #weareanticancer
UCI Anti-Cancer Challenge 2017 Impact report #weareanticancer Your support of the UCI Anti-Cancer Challenge is planting the seeds from which UCI research will grow to improve cancer therapies! As Orange
More informationRUNX1 and FPD/AML Translational Research. The Leukemia and Lymphoma Society / Babich Family Foundation Partnership. September 2016
www.lls.org www.runx1.com RUNX1 and FPD/AML Translational Research The Leukemia and Lymphoma Society / Babich Family Foundation Partnership September 2016 Prepared by L. Greenberger, PhD Chief Scientific
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28
More informationAdvances in Brain Tumor Research: Leveraging BIG data for BIG discoveries
Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu
More information2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More information2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
More informationCancer Biology Course. Invasion and Metastasis
Cancer Biology Course Invasion and Metastasis 2016 Lu-Hai Wang NHRI Cancer metastasis Major problem: main reason for killing cancer patients, without it cancer can be cured or controlled. Challenging questions:
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More informationNovel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates
Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Christopher Turner, MD Vice President, Clinical Science 04 November 2016 Uveal Melanoma Celldex Pipeline CANDIDATE INDICATION Preclinical
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More informationStarr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May 1-2, 2017 Monday, May 1, 2017
Starr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May -, 07 Monday, May, 07 9:00 :00 am Attendee Arrival and Check In (Grace Auditorium Lobby) :00 am Welcome and Opening Remarks Bruce Stillman
More informationBMT Winter Workshop. 3:05-6:20 PM Workshop - 18 speakers. (Break: 4:35PM)
BMT Winter Workshop Friday, December 8 th, 2017 The Carter Center, Atlanta, GA Workshop Focus: 1. Conditioning Relapse 2. CART 3. Biomarkers & GvHD 4. Microbiota Agenda: 2:00 2:30 PM Speakers Arrive to
More informationNational Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant
National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The National Surgical
More informationSummary of Research and Writing Activities in Oncology
Summary of Research and Writing Activities in Oncology Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts, Posters,
More informationSupplemental Table 1.1: Prostate cancer prognostic tools
Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical
More informationTumor responses (patients responding/ patients treated)
Table 1. ACT clinical trial tumor responses and toxicities. a Target antigen Cancer(s) Receptor type Tumor responses (patients responding/ patients treated) Immune-mediated toxicities (patients experiencing
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationPLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:
More informationCertified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)
Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018) I. Coordination of Care - 26% A. Breast health, screening, early detection, risk assessment and reduction 1. Issues related to
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY NFORMATON n format provided by Melero et al. (AUGUST 2015) Supplementary nformation S3 Combinations including two or more immunotherapy agents based on PD-1/PD-L1 blockade. (Source: https://clinicaltrials.gov/
More information3 rd Berlin Cancer Retreat - Agenda
3 rd Berlin Cancer Retreat - Agenda Wednesday, 5 October 2016 8:30 9:00 Registration 9:00 9:10 Welcome and Introduction Program Exploitation of Oncogenic Mechanisms Ulrike Stein 9:10 9:25 Targeting Myc
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationList of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
More informationMarch 2018 (i2i-18) Competition Awarded Innovation to Impact Grants Listed by panel in alphabetical order
I1a March 2018 (i2i-18) Competition Awarded Innovation to Impact Grants Listed by panel in alphabetical order Biomarkers and Genomics Brooks-Wilson, Angela Genetic buffering in cancer The risk of many
More informationTrial no. Status Phase Treatment Pre-conditioning Primary endpoints Secondary endpoints Diagnosis Sponsor
Supplemental table 1. Overview of recent clinical phase I and II trials assessing the safety and efficacy of TCR-modified T cells in cancer patients as registered at clinicaltrials.gov by September 1,
More information別紙 No. 掲載雑誌名 ISSN Impact Factor (2016) 1 Acs Nano Acta Biomaterialia Acta Crystallographica Section D-Structural
別紙 1 Acs Nano 1936-0851 13.942 2 Acta Biomaterialia 1742-7061 6.319 3 Acta Crystallographica Section D-Structural Biology 0907-4449 2.114 4 Acta Neuropathologica 0001-6322 12.213 5 Acta Ophthalmologica
More informationPredictive Biomarkers in GBM
Predictive Biomarkers in GBM C. David James, Ph.D. Professor & Associate Director, Brain Tumor Research Center Dept. Neurological Surgery and Helen Diller Comprehensive Cancer Center, University of California
More informationImmune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment
Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President
More informationRegistration Continental Breakfast. Histone Modifications and Cancer- Part 1
Miami Epigenetics & Cancer Symposium Sunday, November 27 Tuesday, November 29, 2016 Ritz-Carlton, Miami Beach Conference Room: Collins for the Office SPEAKERS PROGRAM Sunday, November 27, 2016 Speakers
More informationCheckpoint Regulators Cancer Immunotherapy takes centre stage. Dr Oliver Klein Department of Medical Oncology 02 May 2015
Checkpoint Regulators Cancer Immunotherapy takes centre stage Dr Oliver Klein Department of Medical Oncology 02 May 2015 Adjuvant chemotherapy improves outcome in early breast cancer FDA approval of Imatinib
More informationCancer Epidemiology. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD
Cancer Epidemiology Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Fanconi Anemia Adults, February 2011 Outline Epidemiology FA Literature
More informationUniversity of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13
University of Pittsburgh Cancer Institute UPMC CancerCenter Uma Chandran, MSIS, PhD chandran@pitt.edu 412-648-9326 2/21/13 University of Pittsburgh Cancer Institute Founded in 1985 Director Nancy Davidson,
More informationSeptember 20, Submitted electronically to: Cc: To Whom It May Concern:
History Study (NOT-HL-12-147), p. 1 September 20, 2012 Re: Request for Information (RFI): Building a National Resource to Study Myelodysplastic Syndromes (MDS) The MDS Cohort Natural History Study (NOT-HL-12-147).
More informationmirna Dr. S Hosseini-Asl
mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region
More informationNeuroblastoma. Elizabeth Roberts. Data Coordinator CIBMTR Data Managers Mentor. Tandem Meeting February 18
Neuroblastoma Elizabeth Roberts Data Coordinator CIBMTR Data Managers Mentor Tandem Meeting February 18 Objectives Know what neuroblastoma is, how it is diagnosed, and how it is treated Complete form 2026:
More informationPosters and Presentations
Posters and Presentations June 2017: American Society of Clinical Oncology (ASCO) Annual - Preliminary Correlative Analysis of PD-L1 expression from the SUNRISE Study. View April 2017: American Association
More informationGRAND ROUNDS SPEAKERS JANUARY 2017 DECEMBER 2017
GRAND ROUNDS S JANUARY 2017 DECEMBER 2017 JANUARY 2017 Monday, January 2, 2017 Monday, January 9, 2017 Monday, January 16, 2017 Monday, January 23, 2017 Monday, January 30, 2017 Cancelled - New Year s
More informationBIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
More informationCancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
More informationBMT Winter Workshop. Agenda: 2:00-3:00 PM Meet and Greet. Friday, November 30 th, The NAT, San Diego, CA
BMT Winter Workshop Friday, November 30 th, 2018 The NAT, San Diego, CA Workshop Focus: Section 1. Allogeneic Stem Cell Transplantation and GVHD Section 2. Novel Approaches in Stem Cell Transplantation
More informationIndex. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A A Complimentary Trial of an Immunotherapy Vaccine Against Tumor-specific EGFRvIII (ACTIVATE), 90 91 Active immunotherapy, 5 8, 96. See
More informationHODGKIN S AND NON-HODGKIN S LYMPHOMA
HODGKIN S AND NON-HODGKIN S LYMPHOMA edited by JOHN P. LEONARD, MD Center for Lymphoma and Myeloma Weill Medical College of Cornell University New York Presbyterian Hospital New York, NY MORTON COLEMAN,
More informationDKTK Local Retreat Partner Site Freiburg
DKTK Local Retreat Partner Site Freiburg November 20 21, 2017 Restaurant Dattler Am Schlossberg 1 Freiburg Talks Day 1, Nov. 20 Session No. Time Chair Talks Intro 08:50 Christoph Peters Early Diagnosis
More informationThe Cancer Genome Atlas & International Cancer Genome Consortium
The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1
More informationNeoantigen Identification using ATLAS Across Multiple Tumor Types Highlights Limitations of Prediction Algorithms
Neoantigen Identification using ATLAS Across Multiple Tumor Types Highlights Limitations of Prediction Algorithms Wendy Broom, Ph.D. Keystone: Translational Systems Immunology, Snowbird February 1st 2018
More informationPediatric Oncology. Vlad Radulescu, MD
Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common
More informationTraining Role. in Training. Junior Mentor. Junior Mentor. Junior Mentor. Page 267
Table 2. Participatg Faculty Members Abou Alaiwa, Mahmoud Ankrum, James Anthony, RT Baek, Stephen Associate Medice - Medice Biomedical & Environmental Health Industrial Bronchoscopy, human Cystic Fibrosis,
More informationHuman Genetics 542 Winter 2018 Syllabus
Human Genetics 542 Winter 2018 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Jan 3 rd Wed Mapping disease genes I: inheritance patterns and linkage analysis
More informationMyelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression
Myelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression Carlos E. Bueso-Ramos, M.D., Ph.D Department of Hematopathology The University of Texas M.
More informationNew Visions in PET: Surgical Decision Making and PET/CT
New Visions in PET: Surgical Decision Making and PET/CT Stanley J. Goldsmith, MD Director, Nuclear Medicine Professor, Radiology & Medicine New York Presbyterian Hospital- Weill Cornell Medical Center
More informationMurtha Cancer Center The DoD Cancer Center of Excellence
Accelerating Progress against Cancer through Collaboration Center of Excellence Oversight Board September 10, 2013 Colonel Craig D. Shriver, MC, USA. FACS Director 1 Summary Murtha Cancer Center Overview
More informationAction to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research
Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers
More informationDiversity Clinical Research Workshop Invited Faculty
Diversity Clinical Research Workshop Invited Faculty Alex A. Adjei, MD, PhD, FACP Professor and Chair, Department of Medicine Senior Vice President of Clinical Research The Katherine Anne Gioia Chair in
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationThe Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley
The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley Department of Genetics Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill What is TCGA? The Cancer Genome
More informationAmerican Cancer Society, Inc. Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-14-013-01 Cole, Allison M., MD MENTOR: Baldwin, Laura-Mae, MD, MPH Department of Family Medicine Improving Colorectal
More informationNew Oncology Drugs: Nadeem Ikhlaque, M.D Subtitle Would Go Here
New Oncology Drugs: A PowerPoint Brief Primer Cover Title Nadeem Ikhlaque, M.D 05.19.2017 Subtitle Would Go Here Learning Objectives List novel chemotherapies and the indications of these newer agents
More informationIntro to Cancer Therapeutics
An Intro to Cancer Therapeutics Christopher R. Chitambar, MD Professor of Medicine Division of Hematology & Oncology Froedtert and Medical College of Wisconsin Clinical Cancer Center cchitamb@mcw.edu Intro
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationQuiz. b. 4 High grade c. 9 Unknown
Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm
More informationCLINICAL APPLICATION OF CAR T CELLS
Memorial Sloan Kettering Cancer Center is pleased to announce CLINICAL APPLICATION OF CAR T CELLS MARCH 10-11, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Zuckerman Research Center
More informationCancer Immunotherapy Survey
CHAPTER 8: Cancer Immunotherapy Survey All (N=100) Please classify your organization. Academic lab or center Small biopharmaceutical company Top 20 Pharma Mid-size pharma Diagnostics company Other (please
More informationTeam Progress Updates. SU2C Pancreatic Dream Team: Cutting Off the Fuel Supply: A New Approach in the Treatment of Pancreatic Cancer
SU2C Pancreatic Dream Team: Cutting Off the Fuel Supply: A New Approach in the Treatment of Pancreatic Cancer Cancer of the pancreas is one of the deadliest forms of cancer, with a five-year survival rate
More informationConference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX
NOTE: Saturday, February 7 1:00 p.m.-3:00 p.m. Session A1: Cancer Genomics and Epigenomics Session Chairperson: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA Genomic heterogeneity in localized
More informationPrecision medicine: How to exploit the growing knowledge on the evolving genomes of cells to improve cancer prevention and therapy.
Precision medicine: How to exploit the growing knowledge on the evolving genomes of cells to improve cancer prevention and therapy Joe Costello, PhD Department of Neurological Surgery A more accurate and
More informationHuman Genetics 542 Winter 2017 Syllabus
Human Genetics 542 Winter 2017 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Module I: Mapping and characterizing simple genetic diseases Jan 4 th Wed Mapping
More informationDONNA BOWERS & ALAN MILLER
BAYLOR HEALTH CARE SYSTEM ONCOLOGY NETWORK NEWS UPDATE WITH YOUR BHCS ONCOLOGY ANCHORS DONNA BOWERS & ALAN MILLER 1 The Evolution of Cancer Care Slash, burn and poison era Precision Medicine Casting out
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More informationACR TXIT TM EXAM OUTLINE
ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity
More informationA View to the Future: The Development of Targeted Therapy for Melanoma. Michael Davies, M.D., Ph.D.
A View to the Future: Science to Survivorship Symposium September 26, 2009 The Development of Targeted Therapy for Melanoma Michael Davies, M.D., Ph.D. Assistant Professor, Melanoma Medical Oncology How
More informationInvited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
More information/ NCCN. ACS (www.cancer.org) NCC (www.nccn.org) NCCN NCCN ACS ACS-2345
/2002 9 /2002 9 (NCCN) (ACS) NCCN ACS (www.cancer.org) NCC (www.nccn.org) NCCN 1-888-909-NCCN ACS 1-800-ACS-2345 NCCN ACS NCCN NCCN ACS NCCN 2002 (NCCN) (ACS) NCCN ACS ...................................
More informationobjectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University
objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand
More informationAccepted Manuscript. Pancreatic Cancer Subtypes: Beyond Lumping and Splitting. Andrew J. Aguirre
Accepted Manuscript Pancreatic Cancer Subtypes: Beyond Lumping and Splitting Andrew J. Aguirre PII: S0016-5085(18)35213-2 DOI: https://doi.org/10.1053/j.gastro.2018.11.004 Reference: YGAST 62235 To appear
More informationMorphogens: What are they and why should we care?
Morphogens: What are they and why should we care? Historic, Theoretical Mechanism of Action Nucleoprotein: the specific trophic cellular material extracted from the cell nucleus. DNA and RNA which regulates
More informationNuclear medicine in oncology. 1. Diagnosis 2. Therapy
Nuclear medicine in oncology 1. Diagnosis 2. Therapy Diagnosis - Conventional methods - Nonspecific radiopharmaceuticals cumulating in tumours - Specific radiopharmaceuticals (receptor- and immunoscintigraphy)
More informationExploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser
Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Melissa S. Cline 1*, Brian Craft 1, Teresa Swatloski 1, Mary Goldman 1, Singer Ma 1, David Haussler 1, Jingchun Zhu 1 1 Center for Biomolecular
More informationBreast Cancer Diagnosis, Treatment and Follow-up
Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce
More informationTranscriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression. Chromatin Array of nuc
Transcriptional control in Eukaryotes: (chapter 13 pp276) Chromatin structure affects gene expression Chromatin Array of nuc 1 Transcriptional control in Eukaryotes: Chromatin undergoes structural changes
More informationChanging AML Outcomes via Personalized Medicine: Transforming Cancer Management with Genetic Insight
Changing AML Outcomes via Personalized Medicine: Transforming Cancer Management with Genetic Insight Co-Moderators: Rick Winneker, PhD, Senior Vice President, Research, Leukemia & Lymphoma Society Mike
More informationPage 1 of 8 TABLE OF CONTENTS
Page 1 of 8 TABLE OF CONTENTS Patient Evaluation and Recommendation..Page 2 Testing and Follow-up..Page 3 Genetic Counseling Referral Criteria.....Page 4-5 Patient Education..Page 6 Suggested Readings...Page
More informationAllinaHealthSystems 1
Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, for early-stage triple-negative breast cancer, 740 742 in older early-stage breast cancer patients, 790 795 anti-her2-directed
More informationImmunotherapy in Colorectal cancer
Immunotherapy in Colorectal cancer Ahmed Zakari, MD Associate Professor University of Central Florida, College of Medicine Medical Director, Gastro Intestinal Cancer Program Florida Hospital Cancer Institute
More informationThe Days of Miracles & Wonder... and Science
Memorial Sloan Kettering Cancer Center is pleased to announce a one day symposium honoring DR. RICHARD J. O REILLY The Days of Miracles & Wonder... and Science Friday, April 28, 2017 Zuckerman Research
More informationBreast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity
Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity WORKING GROUP: This report will be written within the Cancer Control Working Group with oversight from the Second Malignant
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationDEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
More informationCCO Annual Report (2016) Editorial Office
CCO Annual Report (2016) Editorial Office editor@thecco.net Outline of the Report 1.Basic Information 2.Message from the Editors-in-Chief 3.Distribution of Editorial Board Members 4.Number of Published
More informationSteamboat Springs, Colorado. January 15-18, 2016
Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status
More information